We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

MEDIX BIOCHEMICA AB

Develops, produces and markets monoclonal antibodies, antibody services and recombinant antigens for IVD industry, as... read more Featured Products: More products

Download Mobile App





Medix Biochemica Celebrates Launch of New Molecular Diagnostic Reagents Division at MEDICA 2021

By LabMedica International staff writers
Posted on 15 Nov 2021
Print article
Image: Medix Biochemica at MEDICA 2021 (Photo courtesy of Medix Biochemica)
Image: Medix Biochemica at MEDICA 2021 (Photo courtesy of Medix Biochemica)

Medix Biochemica (Espoo, Finland) celebrated the launch of its new molecular diagnostic reagents division, MedixMDx at this year's MEDICA, the world's largest annual medical technology trade fair, which took place from 15-18 November in Düsseldorf, Germany.

Medix, including Lee Biosolutions, EastCoast Bio and Diaclone, is a leading global supplier of critical raw materials used for in vitro diagnostics (IVD). Medix recently acquired Diaclone, a prominent provider of monoclonal antibodies in the areas of inflammation, oncology, and immunology. At MEDICA 2021, Medix showcased its wide portfolio of monoclonal antibodies, antigens for immunoassay materials, molecular diagnostics reagents, enzymes for clinical chemistry controls, and biochemicals and biological.

Medix highlighted its range of quality reagents offered through MedixMDx in combination with a host of custom services to provide IVD kit manufacturers, labs and research institutions with the tailored support they need from proof-of-concept right through to release for sale. In addition to highlighting its wide range of high-quality reagents and master mixes designed to shorten development timelines and work with various assay technologies, Medix also threw light on its technical support provided to clients as they develop their assays as well as contract manufacturing services.

Medix highlighted its broad range of platform-agnostic reagents, including enzymes, nucleic acid extraction products, buffers and as well as consumables. The company showcased its range of enzymes, ready mixes, controls, clinical specimens and general reagents in the areas of PCR/qPCR, isothermal nucleic acid amplification technologies (iNAAT), Next generation Sequencing (NGS).

Related Links:
Medix Biochemica 

New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
New
Electroporation System
Gibco CTS Xenon
New
hCG Urine Test
QuickVue hCG Urine Test

Print article

Channels

Molecular Diagnostics

view channel
Image: The groundbreaking genomics method has the potential to uncover insights previously missed (Photo courtesy of Breakthrough Genomics)

Groundbreaking Blood Test Detects Earliest Signs of Pancreatic Cancer Before Symptoms Appear

Pancreatic cancer often remains undetected until it has progressed beyond the pancreas, typically because it presents no noticeable symptoms in its early stages. Consequently, pancreatic cancer has one... Read more

Hematology

view channel
Image: The new test could improve specialist transplant and transfusion practice as well as blood banking (Photo courtesy of NHS Blood and Transplant)

New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape

The release of oxygen by red blood cells is a critical process for oxygenating the body's tissues, including organs and muscles, particularly in individuals receiving large blood transfusions.... Read more

Immunology

view channel
Image: Concept for the device. Memory B cells able to bind influenza virus remain stuck to channels despite shear forces (Photo courtesy of Steven George/UC Davis)

Microfluidic Chip-Based Device to Measure Viral Immunity

Each winter, a new variant of influenza emerges, posing a challenge for immunity. People who have previously been infected or vaccinated against the flu may have some level of protection, but how well... Read more

Microbiology

view channel
Image: The iFAST reader scans 5000 individual bacteria with each sample analyzed in less than a minute (Photo courtesy of iFAST)

High-Throughput AST System Uses Microchip Technology to Rapidly Analyze Bacterial Samples

Bacteria are becoming increasingly resistant to antibiotics, with resistance levels ranging from 20% to 98%, and these levels are unpredictable. Currently, antimicrobial susceptibility testing (AST) takes... Read more

Pathology

view channel
Image: These images show the high resolution achieved with the new microscopy technique (Photo courtesy of Cao, R. et al. Science Advance, 2024. Caltech)

New Microscopy Technique Enables Rapid Tumor Analysis by Surgeons in OR

The current standard method for quickly sampling and imaging tissue during surgery involves taking a biopsy, freezing the sample, staining it to enhance visibility, and slicing it into thin sections that... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.